Cargando…

Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial

INTRODUCTION: Chronic facial nerve palsy has long been known to negatively affect the quality of life in patients. The present study aimed to investigate the efficacy of Botulinum Toxin A (BTX-A) and neuromuscular retraining therapy (NMRT) in the symmetry of chronic facial palsy. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourmomeny, Abbas Ali, Pourali, Elham, Chitsaz, Ahamd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231305/
https://www.ncbi.nlm.nih.gov/pubmed/34222106
http://dx.doi.org/10.22038/ijorl.2021.41305.2347
_version_ 1783713400969232384
author Pourmomeny, Abbas Ali
Pourali, Elham
Chitsaz, Ahamd
author_facet Pourmomeny, Abbas Ali
Pourali, Elham
Chitsaz, Ahamd
author_sort Pourmomeny, Abbas Ali
collection PubMed
description INTRODUCTION: Chronic facial nerve palsy has long been known to negatively affect the quality of life in patients. The present study aimed to investigate the efficacy of Botulinum Toxin A (BTX-A) and neuromuscular retraining therapy (NMRT) in the symmetry of chronic facial palsy. MATERIALS AND METHODS: Two groups, namely experimental and control, were considered each consisting of 13 patients. The study population included a total of 15 female subjects. The BTX-A was injected into the synkinetic muscle in the experimental group; nevertheless, the patients in the second group participated in special neuromuscular retraining. The rate of reducing synkinesis and symmetrical improvement was evaluated using the Facial Grading System (FGS) after 4 months of treatment. The independent t-test was performed to compare the two groups. RESULTS: According to the Sunnybrook FGS, the mean changes in Sunnybrook scores in the experimental and neuromuscular retraining groups were 3% and 24%, respectively. The comparison of the mean scores of the two groups was statistically significant after the interventions (P=0.033). A variable ratio of statistically significant improvement was observed in synkinesis in both groups following the treatment (P=0.041). In addition, by comparing the synkinesis scores between the two groups, the reduction of synkinesis was observed to be greater in the neuromuscular retraining group (P=0.041) after the treatment. CONCLUSIONS: The findings of the current study indicated that special neuromuscular retraining leads to significant improvement in the FGS score, compared to botulinum toxin therapy alone. Moreover, it was observed that facial symmetry can be treated with special neuromuscular retraining and the patient can overcome synkinesis.
format Online
Article
Text
id pubmed-8231305
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-82313052021-07-01 Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial Pourmomeny, Abbas Ali Pourali, Elham Chitsaz, Ahamd Iran J Otorhinolaryngol Original Article INTRODUCTION: Chronic facial nerve palsy has long been known to negatively affect the quality of life in patients. The present study aimed to investigate the efficacy of Botulinum Toxin A (BTX-A) and neuromuscular retraining therapy (NMRT) in the symmetry of chronic facial palsy. MATERIALS AND METHODS: Two groups, namely experimental and control, were considered each consisting of 13 patients. The study population included a total of 15 female subjects. The BTX-A was injected into the synkinetic muscle in the experimental group; nevertheless, the patients in the second group participated in special neuromuscular retraining. The rate of reducing synkinesis and symmetrical improvement was evaluated using the Facial Grading System (FGS) after 4 months of treatment. The independent t-test was performed to compare the two groups. RESULTS: According to the Sunnybrook FGS, the mean changes in Sunnybrook scores in the experimental and neuromuscular retraining groups were 3% and 24%, respectively. The comparison of the mean scores of the two groups was statistically significant after the interventions (P=0.033). A variable ratio of statistically significant improvement was observed in synkinesis in both groups following the treatment (P=0.041). In addition, by comparing the synkinesis scores between the two groups, the reduction of synkinesis was observed to be greater in the neuromuscular retraining group (P=0.041) after the treatment. CONCLUSIONS: The findings of the current study indicated that special neuromuscular retraining leads to significant improvement in the FGS score, compared to botulinum toxin therapy alone. Moreover, it was observed that facial symmetry can be treated with special neuromuscular retraining and the patient can overcome synkinesis. Mashhad University of Medical Sciences 2021-05 /pmc/articles/PMC8231305/ /pubmed/34222106 http://dx.doi.org/10.22038/ijorl.2021.41305.2347 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Pourmomeny, Abbas Ali
Pourali, Elham
Chitsaz, Ahamd
Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
title Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
title_full Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
title_fullStr Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
title_full_unstemmed Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
title_short Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
title_sort neuromuscular retraining versus btx-a injection in subjects with chronic facial nerve palsy, a clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231305/
https://www.ncbi.nlm.nih.gov/pubmed/34222106
http://dx.doi.org/10.22038/ijorl.2021.41305.2347
work_keys_str_mv AT pourmomenyabbasali neuromuscularretrainingversusbtxainjectioninsubjectswithchronicfacialnervepalsyaclinicaltrial
AT pouralielham neuromuscularretrainingversusbtxainjectioninsubjectswithchronicfacialnervepalsyaclinicaltrial
AT chitsazahamd neuromuscularretrainingversusbtxainjectioninsubjectswithchronicfacialnervepalsyaclinicaltrial